Description
While hundreds of mRNAs accumulate in neurites upon TDP-43 dysfunction, the study doesn’t identify which transcripts are pathologically relevant. Determining the critical mislocalized mRNAs is essential for understanding disease mechanisms and developing targeted interventions.
Gap type: open_question Source paper: TDP-43 directly inhibits mRNA accumulation in neurites through modulation of mRNA stability. (2026, The EMBO journal, PMID:41398473)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:44.939939+00:00”, “resolution_summary”: “Resolved by hypothesis h-var-37240814a5: SASP-Secreted MMP-9 from Senescent Microglia Disrupts Nuclear-Cytoplasmic Transport Leading to TDP-43 Mislocalization and ALS Pathology. Supporting evidence includes debate sess_SDA-2026-04-07-gap-pubmed-20260406-062141-611cf046_task_9aae8fc5.”, “match_counts”: {“hypothesis_matches”: 5, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-var-37240814a5”, “title”: “SASP-Secreted MMP-9 from Senescent Microglia Disrupts Nuclear-Cytoplasmic Transport Leading to TDP-43 Mislocalization and ALS Pathology”, “score”: 0.352, “reason”: “7 token overlaps; entity overlap: als, tdp-43”, “analysis_id”: “SDA-2026-04-26-gap-20260425215446”, “target_gene”: “MMP9 → NUP62/NUP88 → TARDBP mislocalization”, “target_pathway”: “Nuclear-cytoplasmic transport”, “disease”: “ALS”, “composite_score”: 0.360979, “confidence_score”: 0.345, “status”: “proposed”, “pubmed_evidence_ids”: [“21209826”, “30458231”, “33300249”, “39067491”]}, {“id”: “h-72c719461c”, “title”: “C9orf72 ASO Treatment Reverses TDP-43 Pathology in ALS/FTD”, “score”: 0.314, “reason”: “3 token overlaps; entity overlap: als, tdp-43”, “analysis_id”: “test-hypothesis-fixtures-v1”, “target_gene”: “C9orf72”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.72, “confidence_score”: 0.88, “status”: “proposed”, “pubmed_evidence_ids”: [“21944792”, “28960178”, “29460270”, “39605053”, “40520109”]}, {“id”: “h-var-a3cfa5bb63”, “title”: “SASP-Secreted MMP-9 from Senescent Microglia Disrupts TDP-43 Nuclear Retention Leading to Cytoplasmic Mislocalization in ALS”, “score”: 0.314, “reason”: “5 token overlaps; entity overlap: als, tdp-43”, “analysis_id”: “SDA-2026-04-26-gap-20260425215446”, “target_gene”: “MMP9 → nuclear import machinery (KPNA1, NUP proteins, LMNA) → TARDBP cytoplasmic mislocalization”, “target_pathway”: “Nuclear-cytoplasmic transport pathway”, “disease”: “ALS”, “composite_score”: 0.510861, “confidence_score”: 0.345, “status”: “proposed”, “pubmed_evidence_ids”: [“21209826”, “30458231”, “33300249”, “39067491”]}, {“id”: “h-alsmnd-54f981ca6a25”, “title”: “TIA1 Low-Complexity Domain Oxidation Drives Aberrant Stress Granule Assembly and TDP-43 Mislocalization in ALS Motor Neurons”, “score”: 0.313, “reason”: “5 token overlaps; entity overlap: als, tdp-43”, “analysis_id”: null, “target_gene”: “TIA1,TDP-43,TARDBP,G3BP1,MAPK1,Oxidative stress response”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.81, “confidence_score”: 0.75, “status”: “open”, “pubmed_evidence_ids”: [“23092511”, “34378050”, “34750982”, “36499097”]}, {“id”: “h-var-a0933e666d”, “title”: “Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 Proteinopathy Neuroinflammation in ALS/FTD”, “score”: 0.311, “reason”: “12 token overlaps; entity overlap: als, tdp-43”, “analysis_id”: “SDA-2026-04-01-gap-20260401-225149”, “target_gene”: “AIM2, CASP1, IL1B, PYCARD, TARDBP”, “target_pathway”: “Microglial AIM2 inflammasome activation via phagocytosed neuron-derived mtDNA in TDP-43 proteinopathy”, “disease”: “neurodegeneration”, “composite_score”: 0.8240000000000001, “confidence_score”: 0.76, “status”: “proposed”, “pubmed_evidence_ids”: [“27519954”, “28506519”, “29263430”, “29643512”, “30610225”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062141-611cf046_task_9aae8fc5”, “title”: “While the study establishes TDP-43 triggers mtDNA release via mPTP to activate cGAS/STING, it’s unclear why this pathway preferentially affects motor neurons in ALS when TDP-43 pathology occurs in multiple cell types. Understanding this selectivity is crucial for targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. (2020, Cell, PMID:33031745)”, “score”: 0.611, “reason”: “9 token overlaps; entity overlap: als, pmid, tdp-43”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062141-611cf046”, “quality_score”: 0.734, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062202-094b44bf_task_9aae8fc5”, “title”: “TDP-43 inclusions occur in AD, ALS, and FTLD but the pathogenic mechanisms leading to TDP-43 pathology may differ between diseases. Understanding disease-specific drivers could reveal why TDP-43 shows limbic distribution in AD versus other patterns in ALS/FTLD.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Pathology in Alzheimer’s Disease. (2021, Mol Neurodegener, PMID:34930382)”, “score”: 0.582, “reason”: “7 token overlaps; entity overlap: als, pmid, tdp-43”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062202-094b44bf”, “quality_score”: 0.697, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062141-fc60e018_task_73907230”, “title”: “The study identifies cGAS/STING activation as a consequence of TDP-43-mediated mtDNA release, but the temporal dynamics and whether this pathway drives chronic inflammation or acute toxicity remains unclear. This distinction is critical for determining therapeutic timing and approach.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. (2020, Cell, PMID:33031745)”, “score”: 0.575, “reason”: “8 token overlaps; entity overlap: als, pmid, tdp-43”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062141-fc60e018”, “quality_score”: 0.73, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-181356-57d1f917”, “title”: “The study shows dramatic functional recovery and muscle re-innervation after cytoplasmic TDP-43 clearance, even following motor neuron death. The cellular and molecular mechanisms underlying this unexpected regenerative capacity in neurodegenerative disease are not explained.\n\nGap type: unexplained_observation\nSource paper: Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. (2015, Acta neuropathologica, PMID:26197969)”, “score”: 0.532, “reason”: “6 token overlaps; entity overlap: als, pmid, tdp-43”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-181356-57d1f917”, “quality_score”: 0.85, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-183548-043c7918”, “title”: “The authors evaluate several ALS-associated mutations in OPTN’s leucine-zipper domain but don’t fully explain how these mutations mechanistically lead to disease pathogenesis. Understanding this link is critical for developing targeted ALS therapies.\n\nGap type: unexplained_observation\nSource paper: Molecular Basis of the Recognition of the Active Rab8a by Optineurin. (2024, Journal of molecular biology, PMID:39374890)”, “score”: 0.53, “reason”: “10 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-183548-043c7918”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}